By Sunderarajan Padmanabhan
New Delhi, September 4 (India Science Wire): Incidence of chronic kidney disease is rising rapidly India. It is ranked as the ninth leading cause of death in India as per the estimates made by a global study in 2016. Among the response mounted to address the challenge was the national dialysis programme launched in 2014, envisaging setting up dialysis centres in all the districts.
A new study now has shown that though free treatment under a publicly funded dialysis programme could allow more people access this expensive treatment, it would not be able to address all barriers to ensure long –term success.
The study is based on an analysis of 13,118 beneficiaries who received haemodialysis over a period of four years (2008-12) for end stage kidney disease under the Rajiv Gandhi Aarogyashri Community Health Insurance Scheme (RACHIS) introduced in 2007 by the Government of unified Andhra Pradesh.
It showed that there was steady rise in number of persons accessing treatment, confirming high unmet need for dialysis but survival rates were suboptimal. About 10 percent of all the people who started haemodialysis had died and another 36 percent had stopped coming to dialysis centres after six months.
The study, done by the George Institute for Global Health India, found that the total cost of dialysis-related care was US dollars 63.2 million, accounting for 3.1 per cent of all claim expenses under the scheme.
Noting that the high drop-out rate had been noticed in smaller studies conducted earlier too, Professor Vivekanand Jha, Executive Director of the George Institute for Global Health, India, said there appeared to be several additional barriers.
“These could include out-of-pocket expenses for travel to dialysis units; management of associated medical conditions the costs of which were not covered by the scheme; loss of income; and caregiver burden. Exploration of these factors requires additional studies”, he said. The study has been published in journal Kidney International.